Vapotherm, Inc. is a medical technology company, which engages in the development and commercialization of medical devices for patients suffering from respiratory distress. The company is headquartered in Exeter, New Hampshire and currently employs 182 full-time employees. The company went IPO on 2018-11-14. The company develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. The company is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories Aspira Women's Health Inc Biomerica Inc Conformis Inc IRIDEX Corp Milestone Scientific Inc Scientific Industries Inc Talis Biomedical Corp